This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Everyone from the board and the C-suite to the health IT team to doctors and nurses are talking about how digital technologies can change the industry and bring about better care and better outcomes. Digital transformation is the topic du jour in healthcare today.
A provider present with the patient at one location – a nursing home, community clinic, etc. Somatix works with elderly care facilities across the care continuum (independent living, assisted living, sub-acute short term care, and nursing homes), hospitals (for the use-case of discharged patients), and substance abuse rehab centers.
For decades, policymakers, CEOs, politicians, doctors, nurses, healthcare workers, caregivers, and anyone who’s been a patient inside or outside a hospital has known one simple fact — the US healthcare system is broken. Cost Plus Drug Company seeks to lower the cost of popular medications for US consumers.
Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drugdevelopment life cycles. DTx has the potential to streamline data collection processes, help providers offer higher quality value-based care, and reduce the burden on doctors and nurses.
DTx could be used in phase II of clinical trials for monitoring patients, helping reduce costs of drugdevelopment and speeding up that phase. It’s also important to differentiate between primary care physicians, specialists and nurses and to define the messages specifically for each group. What should be the best market access?
Or, picture a nurse receiving real-time guidance from an AI assistant on administering medication to a critically ill patient. Dosage Optimisation: AI can optimise drug dosages to minimise side effects and maximize therapeutic benefits. These are just glimpses into the potential of co-pilot technologies in healthtech.
Precision medicine will continue to evolve in 2024: In disease areas like oncology, we will start to see AI playing a larger role in target discovery and biomarker or patient subpopulation identification, the cornerstones to early precision drugdevelopment.
Drugdevelopment The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates. There are three main advantages to the use of AI in drugdevelopment: width of research, speed of execution, low costs.
When doctors, nurses, and other care workers are stretched thin by administrative tasks and busy work, there is the potential for it to become far more difficult for them to provide the kind of individualized care that patients deserve. We’re already seeing the benefits of AI-infused research in pharmaceuticals and drugdevelopment.
Katherine Seay, Executive Vice President at Clinical Trial Media Diversity in healthcare needs to extend to every corner of the industry, from healthcare practitioners to the drugdevelopment and discovery process. One area where the need for diversity has never been greater is clinical trials.
Officials said use was largely driven by people accessing COVID-19 vaccination records and test results – in fact, less that 2% of patients who went to the emergency department had doctors or nurses look at their records. The Office of the National Coordinator for Health IT has some money for you.
This flagship initiative is a natural extension of prior WBF forums in which the importance of determining sex and gender differences has been discussed with the entire healthcare ecosystem – policymakers, academia, patient association, drugdevelopers, regulators and funding agencies. About WebMD Health Corp.
Yet, time and again, coordinated efforts by paramedics, surgeons, and nurses, even with limited resources or chaotic conditions, pull off near-miraculous recoveries. Even in drugdevelopment, happy accidents align with this idea. A sloppy lab setup should have been a write-off, but instead, it birthed antibiotics.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content